Cell isolation is being widely used in the healthcare sector to facilitate the production of biopharmaceuticals and early detection of diseases. Cell separation or isolation techniques are applied in the manufacturing of biopharmaceuticals, such as biosimilars, monoclonal antibodies, and recombinant proteins. Since the cells are derived from plant, human, and animal sources, they need a more scrutinized filtration system to prevent contamination by bacteria and viruses.
Moreover, a surge in government investment and funding is leading to an advancement in the technologies used for cell isolation and pharmaceutical production. The funding for cell-based research is rising worldwide to come up with better ways to treat and control cancer and other chronic ailments. Due to these developments, the demand for cell separation procedures is escalating, which, in turn, is expected to propel the cell isolation market at a CAGR of 18.8% during 2018–2023. According to P&S Intelligence, the market was valued at $4.6 billion in 2017, and it is expected to reach $12.6 billion by 2023.
The various applications of cell isolation techniques include biomolecule isolation, stem cell research, in-vitro diagnostics, cancer research, tissue regeneration, and therapeutics. Due to the growing focus of pharmaceutical companies on the development of biomolecule-based drugs, which display fewer side-effects than other classes of medicines, the usage of cell separation techniques is rising for biomolecule isolation. As a result, the demand for different consumables, such as kits, sera, beads, reagents, media, and disposables, is increasing faster than for instruments.
Additionally, the categories under the end user segment of the cell isolation market include research laboratories and institutes, cell banks, biotechnology and biopharmaceutical companies, and hospitals and diagnostic laboratories,. Among these, the research laboratories and institutes category dominated the market in 2017 due to the widescale adoption of cell isolation techniques for research purposes. During the forecast period, the hospitals and diagnostic laboratories category is expected to display the fastest growth. This can be ascribed to the surging incidence of bacterial and viral infections, which is why cell isolation products are being widely used in such settings for isolating and identifying the pathogens using cell culture.
The North American cell isolation market generated the highest revenue in 2017 due to the presence of a significant number of academic and research institutes, hospitals and diagnostic laboratories, and pharmaceutical and biotechnology firms. All of them are involved in extensive research using cell isolation consumables and methods. The Asia-Pacific (APAC) market is to exhibit the fastest growth during the forecast period owing to the rising focus on applied and basic research, developing healthcare infrastructure, existence of numerous research institutions, and availability of technologically advanced cell isolation products in this region.
Access Detailed Report on Cell Isolation Market Revenue Estimation- https://www.psmarketresearch.com/market-analysis/cell-isolation-market
